Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study by Tellapragada, C. (C.) et al.
lable at ScienceDirect
Clinical Microbiology and Infection xxx (xxxx) xxxContents lists avaiClinical Microbiology and Infection
journal homepage: www.cl inicalmicrobiologyandinfect ion.comOriginal articleIsothermal microcalorimetry minimal inhibitory concentration testing
in extensively drug resistant Gram-negative bacilli: a multicentre
study*
C. Tellapragada 1, B. Hasan 1, A. Antonelli 3, 4, A. Maruri 5, C. de Vogel 6, D. Gijon 5,
M. Coppi 3, 4, A. Verbon 6, W. van Wamel 6, G.M. Rossolini 3, 4, R. Canton 5, C.G. Giske 1, 2, *
1) Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institute, Stockholm, Sweden
2) Division of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
3) Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
4) Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy
5) Servicio de Microbiología. Hospital Universitario Ramon y Cajal e Instituto Ramon y Cajal de Investigacion Sanitaria (IRYCIS), Madrid, Spain
6) Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, the Netherlandsa r t i c l e i n f o
Article history:
Received 30 September 2019
Received in revised form
27 December 2019
Accepted 21 January 2020
Available online xxx
Editor: P. T. Tassios
Keywords:
Broth microdilution
Categorical agreement
Essential agreeme
Extensively drug-resistant (XDR) bacteria
Isothermal microcalorimetry
Minimal inhibitory concentration* Presented in part at the 29th European Congress
Infectious Diseases (ECCMID), April 2019, Amsterdam
* Corresponding author. C.G. Giske, Division of Clini
of Laboratory Medicine, Karolinska Institute, Alfred No
Sweden.
E-mail address: christian.giske@ki.se (C.G. Giske).
https://doi.org/10.1016/j.cmi.2020.01.026
1198-743X/© 2020 The Authors. Published by Elsevier
the CC BY-NC-ND license (http://creativecommons.or
Please cite this article as: Tellapragada C e
resistant Gram-negative bacilli: a multicenta b s t r a c t
Objectives: To evaluate the performance of an isothermal microcalorimetry (IMC) method for deter-
mining the MICs among extensively drug-resistant Gram-negative bacilli.
Methods: A collection of 320 clinical isolates (n ¼ 80 of each) of Escherichia coli, Klebsiella pneumoniae,
Pseudomonas aeruginosa and Acinetobacter baumannii from Sweden, Spain, Italy and the Netherlands
were tested. The MICs were determined using the IMC device calScreener (Symcel, Stockholm, Sweden)
and ISO-broth microdilution as the reference method. Essential agreement, categorical agreement, very
major errors (VME), major errors (ME) and minor (mE) errors for each antibiotic were determined.
Results: Data from 316 isolates were evaluated. Four errors (two ME, one VME, one mE) among 80
K. pneumoniae, six errors (four ME, one VME, one mE) among 79 E. coli, 15 errors (seven VME, three ME,
ﬁve mE) among 77 P. aeruginosa and 18 errors (12 VME, two ME, four mE) among 80 A. baumannii were
observed. Average essential agreement and categorical agreement of the IMC method were 96.6% (95%
conﬁdence interval, 94.2e99) and 97.1% (95% conﬁdence interval, 95.4e98.5) respectively when the MICs
were determined at the end of 18 hours. Categorical agreement of the IMC method for prediction of MIC
by the end of 8 hours for colistin, meropenem, amikacin, ciproﬂoxacin and piperacillin/tazobactam were
95%, 91.4%, 94%, 95.2% and 93.7% respectively.
Conclusions: The IMC method could accurately determine the MICs among extensively drug-resistant
clinical isolates of E. coli, K. pneumoniae, P. aeruginosa and A. baumannii isolates. C. Tellapragada, Clin
Microbiol Infect 2020;▪:1
© 2020 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Early detection of microbial aetiology and initiation of
pathogen-speciﬁc antimicrobial therapy are crucial pillars forof Clinical Microbiology and
, The Netherlands.
cal Microbiology, Department
bels Alle 8, 14183 Stockholm,
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re study, Clinical Microbiologsuccessful management of clinical infections. Despite the advent of
DNA-based detection methods for pathogens and antimicrobial
resistance genes directly in clinical specimens, microbiologic cul-
ture followed by antimicrobial susceptibility testing (AST) remains
the reference method for diagnosis of bacterial infections. For AST
and determining the MICs against important antimicrobial agents,
themajority of clinical laboratories worldwide usewell-established
methods such as the disc diffusion test and broth microdilution
(BMD) assays. With the global upsurge in the prevalence of in-
fections, particularly due to multidrug-resistant bacteria, quanti-
fying antimicrobial resistance by determining the MICs becomesof Clinical Microbiology and Infectious Diseases. This is an open access article under
etry minimal inhibitory concentration testing in extensively drug
y and Infection, https://doi.org/10.1016/j.cmi.2020.01.026
Table 1
Antibiotics and concentration range
Microorganism Drug (concentration range)
Escherichia coli and
Klebsiella pneumoniae
Amikacin (4e16 mg/L)
Cefotaxime (0.12e4 mg/L)
Ciproﬂoxacin (0.03e1 mg/L)
Meropenem (0.06e16 mg/L)
Piperacillin/tazobactama (2e32 mg/L)
Pseudomonas aeruginosa Amikacin (4e16 mg/L)
Ceftazidime (4e16 mg/L)
Cefepime (4e16 mg/L)
Ciproﬂoxacin (0.25e2 mg/L)
Colistin (1e8 mg/L)
Meropenem (1e32 mg/L)
Piperacillin/tazobactama (8e32 mg/L)
Acinetobacter baumannii Amikacin (2e16 mg/L)
Ciproﬂoxacin (0.25e4 mg/L)
Colistin (0.5e8 mg/L)
Meropenem (0.5e16 mg/L)
Minocycline (0.5e8 mg/L)
Sulbactam (2e16 mg/L)
a Fixed concentration of tazobactam at 4 mg/L was used throughout.
C. Tellapragada et al. / Clinical Microbiology and Infection xxx (xxxx) xxx2indispensable. Currently available automated or semiautomated
systems for AST and MIC determination against commonly used
antimicrobial agents often remain prone to error or less calibrated
compared to BMD [1,2]. Moreover, the majority of these systems
provide results by the end of 16 to 18 hours of incubation, which is
nearly the same amount of time required usingmanual methods. In
this context, clinical laboratories continue to face the challenge of
providing timely and reliable MIC results, which in turn are crucial
for effective antimicrobial stewardship programmes.
Isothermal microcalorimetry (IMC) is a well-acknowledged
method for measuring the energy released during metabolic pro-
cesses in a biological system. Metabolically active bacteria generate
energy which is proportional to their growth rate in a given culture
system. IMC is capable of measuring the energy released in an
isothermal, closed system at microwatt levels and this property
makes it a potential tool to study the growth kinetics of bacteria
[3,4]. IMC has several advantages compared to traditional assay
technologies for studying AST. The technology has a very high
sensitivity compared to optical readouts, enabling a potential early
detection of inhibition. The IMC technology can be used under a
variety of media conditions, and being a label-free technology, it
can also be applied for measurement of samples with complex
geometries such as turbid or complex samples. IMC has been used
to study the mode of action of various antimicrobial agents when
used at subinhibitory concentrations [5]. Exposure of bacteria to
antimicrobials inﬂuences their metabolism and physiology, thereby
affecting the energy released. Isothermal microcalorimetry is a
real-time monitoring of the energy release/heat ﬂow that can help
us better understand the inﬂuence of an antimicrobial agent on the
bacterial growth given time-resolved data. There are currently few
data regarding the accuracy and speed of IMC in predicting the
MICs in the published literature.
We conducted a multicentre evaluation of the performance of
a 48-well IMC device calScreener (Symcel, Stockholm, Sweden),
to determine the MICs among clinical isolates of Escherichia coli,
Klebsiella pneumoniae, Pseudomonas aeruginosa and Acineto-
bacter baumannii against clinically important antimicrobial
agents.
Materials and methods
Study details
We present here the data from an ongoing (January 2018 to
December 2019) multicentre laboratory-based evaluation study.
Study sites were the clinical microbiologic laboratories at Kar-
olinska University Hospital, Sweden; Azienda Universitario Ospe-
daliera Careggi, Italy; Hospital Universitario Ramon y Cajal, Spain;
and Erasmus Medical Center, Netherlands.
Study isolates, antibiotics and media
Nonreplicate clinical isolates of E. coli (n ¼ 80), Klebsiella pneu-
moniae (n¼ 80), Pseudomonas aeruginosa (n¼ 80) and A. baumannii
(n ¼ 80) with pre-determined antimicrobial susceptibility proﬁles
were included in the study. Multiple isolates from known ongoing
outbreaks were avoided. Challenge isolates included in the present
study from all the four study sites were chosen to overrepresent
resistance. Reference strains of E. coli (ATCC 25922 and NCTC
13476), K. pneumoniae (NCTC 13438), P. aeruginosa (ATCC 28753)
and A. baumannii (ATCC 19606) were used for the initial stan-
dardization and reproducibility testing of the protocol for MIC
determination using calScreener. Antibiotics used in the present
study with their concentrations are listed in Table 1. Antibiotic
powders used in the present study were procured from Sigma-Please cite this article as: Tellapragada C et al., Isothermal microcalorim
resistant Gram-negative bacilli: a multicentre study, Clinical MicrobiologAldrich (Sweden). Mueller-Hinton broth (MHB) (Sigma-Aldrich)
was used as the standard growth medium through the study. Cul-
ture media and working solutions of antibiotics used for MIC
determination were prepared according to the guidelines from the
European Committee on Antimicrobial Susceptibility Testing
(EUCAST) v.5.0 (http://eucast.org/ast_of_bacteria/media_
preparation/).Inoculum and antibiotic preparation for calScreener
BMD solutions were prepared in 48- or 96-well microtitre
plates. For each antibiotic, a two-fold dilution series was pre-
pared following the concentration ranges on Table 1 in a total
volume of 150 mL at double the ﬁnal concentration used. Bacterial
suspensions were prepared in MHB and matched to 0.5 McFar-
land and diluted 1:100 in MHB. A total of 150 mL of bacterial
suspensions was inoculated in each well containing antibiotics. In
each plate there were control wells: one negative control that
had only MHB, two positive control wells that had MHB and the
bacterial inoculum but not the antibiotics. From this master plate,
120 mL of each sample (5  105 CFU/mL bacterial suspension with
or without antibiotic) were transferred to sterile plastic inserts
designed to ﬁt in titanium measurement vials (calWell; Symcel)
as a part of the calScreener sample handling system [6,7]. The
inserts were placed in the calWells, sealed and loaded in the
calScreener. The calWells serving as thermodynamic references
were loaded with 120 mL of MHB. Real-time measurement of the
heat produced from each calWells was carried out at
37 ± 0.001C in the calScreener for a minimum duration of
18 hours. The remaining samples in the microtitre plate were
incubated at 37C for 16 to 18 hours.Performance evaluation of IMC method
ISO-broth microdilution (ISO-BMD) was used as the reference
method for evaluation of the IMCmethod. Interpretation of theMIC
results was carried out using the EUCASTclinical breakpoint criteria
(v.9.0, January 2019). Isolates that produced discrepant results (very
major errors and major errors) using the IMC method were sub-
jected to repeat testing (three times) by the reference method.
Overall essential and categorical agreements of the IMC method
were analysed according to the criteria in ISO standards 20776-1
and 20776-2 [8].etry minimal inhibitory concentration testing in extensively drug
y and Infection, https://doi.org/10.1016/j.cmi.2020.01.026
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The heat produced in the calWells was continuously measured
and expressed as heat ﬂow over time (mW) using the manufactur-
er's calView software (Symcel). The initial 30 minutes of incubation
after signal stabilization was used as baseline to correct for internal
sample variation. Isolates that released heat of at least >10 mW,
which allowed us to set a stable baseline, were all included in the
analysis. The total heat released by each isolate was calculated for
every 30-minute interval; the relative heat was then deﬁned as the
total heat ratio between samples exposed to antibiotics and the
positive control (no antibiotic). When a ratio surpassed 20%, it was
considered positive growth, and if it did not surpass the cutoff for
the duration of the assay (8 or 18 hours), it was considered negative.
MIC was deﬁned as the antimicrobial concentration that inhibited
the heat release [9]. Statistical analysis was performed by GraphPad
Prism 8.0 software (GraphPad Software, La Jolla, CA, USA).
Results
Evaluation of the calScreener using reference strains
MICs against the panel of antibiotics (Table 1) for each of the ﬁve
reference strains were determined three times independently at all
four study sites. The reference strains used in the present study
covered the quality control (QC) for all drugs with published QC
ranges. All of the four study sites obtained on-scale results for the
reference strains for the drugs tested within the published QC
ranges for those organisms. Overall, the average categorical and
essential agreements between both the methods were 91.6% and
97.2% respectively. There was a high reproducibility between sitesTable 2
Distribution of study isolates based on MICs against tested antibiotics using reference m
Antimicrobial agent and microorganism No. of isolates with MIC (mg/L):
0.03 0.06 0.12 0.25 0.5
Piperacillin/tazobactam
Escherichia coli d d d d d
Klebsiella pneumoniae d d d d d
Pseudomonas aeruginosa d d d d d
Ciproﬂoxacin
E. coli 37 (46.2) 1 (1.2) 1 (1.2) 5 (6.2) 1 (1.2)
K. pneumoniae 34 (42) 1 (1.2) 5 (6.2) 1 (1.2) 0
P. aeruginosa 40 (50) 3 (3.7)
Acinetobacter baumannii 26 (32) 5 (6.2)
Amikacin
E. coli d d d d d
K. pneumoniae d d d d d
P. aeruginosa d d d d d
A. baumannii d d d d d
Meropenem
E. coli d 57 (71) 3 (3.7) 1 (1.2) 3 (3.7)
K. pneumoniae d 48 (60) 2 (2.5) 1 (1.2) 2 (2.5)
P. aeruginosa d d d d d
A. baumannii d d d d 33 (41)
Cefotaxime
E. coli d d 40 (50) 2 (2.5) 2 (2.5)
K. pneumoniae d d 34 (42) 2 (2.5) 4 (5)
Colistin
P. aeruginosa d d d d d
A. baumannii d d d d 27 (34)
Minocycline
A. baumannii d d d d 33 (41)
Sulbactam
A. baumannii d d d d d
Cefepime
P. aeruginosa d d d d d
Ceftazidime
P. aeruginosa d d d d d
Please cite this article as: Tellapragada C et al., Isothermal microcalorim
resistant Gram-negative bacilli: a multicentre study, Clinical Microbiologdetermining the MIC values: in 95.3% of the tests, all four sites
determined the same MIC using the calScreener, and in 99% of all
tests, the MIC was determined within a single twofold dilution
difference.
Evaluation of calScreener using clinical isolates
We tested 320 clinical isolates comprising 80 of each E. coli, K.
pneumoniae, P. aeruginosa and A. baumannii using both IMC and
ISO-BMDmethods. Distribution of the study isolates based on their
MICs against the tested antibiotics using ISO-BMD method is
depicted in Table 2. Among these 320 isolates, IMC data from 316
(98.7%) could be analyzed and compared to the ISO-BMD results.
IMC data from three P. aeruginosa and one E. coli isolate could not be
analyzed as a result of the very low amount of heat released (<10
mW) by these isolates. For the 316 isolates included in the analysis,
average essential and categorical agreements of the IMCwere 96.6%
(95% conﬁdence interval, 94.2e99) and 97.1% (95% conﬁdence in-
terval, 95.4e98.5) respectively. Total number of isolates tested
against each antibiotic and the percentage of essential and cate-
gorical agreements observed are listed in Table 3.
We deduced the error rates of the IMC method among each of
the four bacterial species included in the study. Six errors (four
major errors (ME), one very major errors (VME) and one minor
error (mE)) were observed among 79 E. coli isolates tested against
ﬁve antibiotics, with an overall error rate of 1.5% (6/395). Four er-
rors (two ME and one each of VME and mE) were observed among
80 K. pneumoniae isolates tested against ﬁve antibiotics, with an
overall error rate of 1% (4/400). Fifteen errors (seven VME, three
ME, ﬁve mE) were observed among 77 P. aeruginosa isolates tested
against seven antibiotics, with an overall error rate of 2.7% (15/539).ethod
Dilution
tested (mg/L)
1 2 4 8 16 32 >32
d 45 (56) 5 (6.2) 3 (3.7) 1 (1.2) 4 (5) 22 (27.5) 2 to >32
d 30 (37) 7 (8.7) 7 (8.7) 2 (2.5) 2 (2.5) 32 (40) 2 to >32
d d d 50 (62) 6 (7.5) 9 (11) 15 (19) 8 to >32
0 35 (43.7) d d d d d 0.03 to >1
1 (1.2) 38 (47.5) d d d d d 0.03 to >1
5 (6.2) 2 (2.5) 30 (37) d d d d 0.25 to >2
2 (2.5) 2 (2.5) 1 (1.2) 36 (45) d d d 0.25 to >4
d d 63 (78) 7 (8.7) 4 (5) 6 (7.5) d 4 to >16
d d 61 (76) 6 (7.5) 5 (6.2) 8 (10) d 4 to >16
d d 51 (64) 6 (7.5) 6 (7.5) 17 (21) d 4 to >16
d 26 (32.5) 15 (19) 3 (3.7) 4 (5) 32 (40) d 2 to >16
2 (2.5) 5 (6.2) 2 (2.5) 2 (2.5) 3 (3.7) 2 (2.5) d 0.06 to >16
3 (3.7) 3 (3.7) 1 (1.2) 3 (3.7) 7 (8.7) 10 (12.5) d 0.06 to >16
46 (57) 3 (3.7) 3 (3.7) 3 (3.7) 3 (3.7) 8 (10) 14 (17.5) 1 to >32
9 (11) 0 0 2 (2.5) 7 (8.7) 29 (36) d 0.5 to >16
2 (2.5) 0 3 (3.7) 31 (39) d d d 0.12 to >4
1 (1.2) 0 1 (1.2) 38 (47) d d d 0.12 to >4
36 (45) 37 (46) 4 (5) 0 3 (3.7) d d 1 to >8
24 (30) 16 (20) 5 (6.2) 2 (2.5) 6 (7.5) d d 0.5 to >8
8 (10) 9 (11) 7 (8.7) 8 (10) 15 (19) d d 0.5 to >8
d 34 (42) 4 (5) 5 (6.2) 9 (11) 28 (35) d 2 to >16
d d 42 (52.5) 12 (15) 5 (6.2) 21 (26) d 4 to >16
d d 47 (59) 4 (5) 8 (10) 21 (26) d 4 to >16
etry minimal inhibitory concentration testing in extensively drug
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Table 3
Overall performance characteristics of IMC for determination of MICs against ten antimicrobial agents
Characteristic COL CAZ FEP MER AMK CIP PTZ CTX SULa MINb
No. of isolates tested 157 77 77 316 316 316 236 159 80 80
No. of isolates with concordant resultsc 151 76 75 309 313 310 236 156 73 72
Essential agreement (%) 96.1 98.7 97.4 97.7 99 98.1 100 98.1 91.2 90
No. of isolates that are:
Resistant 19 27 23 89 77 160 83 72 42 29
Susceptible 138 50 54 221 239 125 153 87 38 51
Susceptible IE d d d 6 d 31 d d d d
VME, n (%) 4 (21) 0 3 (13) 0 4 (5.1) 0 1 (1.2) 0 3 (7.1) 6 (20.6)
ME, n (%) 2 (1.4) 1 (2) 1 (1.8) 1 (0.4) 2 (0.8) 3 (2.4) 0 1 (1.1) 0 0
mE, n (%) 0 0 0 7 (2.2) 0 4 (1.2) 0 0 0 0
Categorical agreement (%) 96.1 98.7 94.8 97.4 98.1 97.7 99.5 99.3 96.2 92.5
AMK, amikacin; CAZ, ceftazidime; CIP, ciproﬂoxacin; COL, colistin; CTX, cotrimoxazole (sulfamethoxazole/trimethoprim); FEP, cefepime; IE, increased exposure; IMC,
isothermal microcalorimetry; ME, major error; mE, minor error; MER, meropenem; MIN, minocycline; PTZ, piperacillin/tazobactam; SUL, sulbactam; VME, very major.
a Tentative epidemiologic cutoff 4 mg/L.
b Tentative epidemiologic cutoff 2 mg/L.
c Isolates with same and/or MICs within 1 log2 dilution compared to ISO-broth microdilution.
C. Tellapragada et al. / Clinical Microbiology and Infection xxx (xxxx) xxx4Eighteen errors (12 VME, two ME, four mE) were observed among
the 80 A. baumannii isolates tested against six antibiotics, with an
overall error rate of 3.7% (18/480).
In the absence of data regarding breakpoints and epidemiologic
cutoffs for minocycline and sulbactam, we assessed the perfor-
mance of the IMC method using two tentative breakpoints for each
drug, 2 and 4 mg/L for minocycline and 4 and 8 mg/L for sulbactam.
The IMC method generated erroneous results more frequently
while testing A. baumannii isolates by producing false susceptible
results against sulbactam (7.1% and 21.6% using 4 and 8 mg/L as the
breakpoints respectively) andminocycline (20.6% and 31.8% using 2
and 4 mg/L as the breakpoints respectively). Performance charac-
teristics of the IMCmethod among the four bacterial species against
individual antibiotics tested in the present study are depicted in
Table 4. For brevity, comparison of the MICs determined using both
the methods against selected antibiotics are depicted in Fig. 1.Table 4
Performance characteristics of IMC method among four bacteria species tested
Organism and performance characteristics COL CAZ FEP M
Escherichia coli (n ¼ 79) NT NT NT
Resistant isolates (n) 6
EA (%) 9
CA (%) 9
VME, n (%) 0
ME, n (%) 0
mE, n (%) 1
Klebsiella pneumoniae (n ¼ 80) NT NT NT
Resistant isolates (n) 2
EA (%) 9
CA (%) 9
VME, n (%) 0
ME, n (%) 1
mE, n (%) 1
Pseudomonas aeruginosa (n ¼ 77)
Resistant isolates (n) 6 27 23 2
EA (%) 98.7 98.7 97.4 9
CA (%) 96.1 98.6 94.8 9
VME, n (%) 2 (33.3) 0 3 (13) 0
ME, n (%) 1 (1.4) 1 (2) 1 (1.8) 0
mE, n (%) 0 0 0 5
Acinetobacter baumannii (n ¼ 80) NT NT
Resistant isolates (n) 13 3
EA (%) 96.2 1
CA (%) 96.2 1
VME, n (%) 2 (15.3) 0
ME, n (%) 1 (1.4) 0
mE, n (%) 0 0
AMK, amikacin; CA, categorical agreement; CAZ, ceftazidime; CIP, ciproﬂoxacin; COL, colis
FEP, cefepime; IMC, isothermal microcalorimetry; ME, major error; mE, minor error; MER
sulbactam; VME, very major.
Please cite this article as: Tellapragada C et al., Isothermal microcalorim
resistant Gram-negative bacilli: a multicentre study, Clinical MicrobiologTime to detection of MIC using the IMC method
Time to detect themetabolic activity for each of the four bacterial
species included in the study was determined. Median time for
detection of a stablemetabolic activity among E. coli, K. pneumoniae,
P. aeruginosa andA. baumanniiwere3, 3.5, 6 and4hours respectively
(Fig. 2(a)). Overall time to detect the MIC of each antibiotic among
each of the four bacterial species is depicted in Figs. 2(bee). We
further compared the categorical errors of the IMC method at two
different timepoints (by theendof8 and18hours) forﬁve important
antibiotics. Average categorical agreement between IMC method at
8 hours and the reference method for colistin, meropenem, amika-
cin, ciproﬂoxacin and piperacillin/tazobactamwere 95%, 91.4%, 94%,
95.2% and 93.7% respectively. Underestimation of resistance for all
the antibiotics testedwasobservedwhen theMICswerepredictedat
8 hours using the IMC data (Fig. 3).ER AMK CIP PTZ CTX SUL MIN
NT NT
9 34 26 33
7.4 100 100 100 100
8.7 97.4 96.2 100 100
1 (12.5) 0 0 0
1 (1.4) 3 (6.6) 0 0
(1.2) 0 0 0 0
NT NT
0 13 39 36 39
6.2 100 95 100 96.2
7.5 100 100 98.7 98.7
0 0 1 (2.7) 0
(1.6) 0 0 0 1 (2.4)
(1.2) 0 0 0 0
NT NT NT
5 19 33 21
7.4 98.7 100 100
3.5 97.4 100 100
2 (10.5) 0 0
0 0 0
(6.5) 0 0 0
NT NT
8 36 54 42 29
00 97.5 97.5 91.2 90
00 97.5 95 96.2 92.5
1 (2.7) 0 3 (7.1) 6 (20.6)
1 (2.2) 0 0 0
0 4 (5) 0 0
tin; CTX, cotrimoxazole (sulfamethoxazole/trimethoprim); EA, essential agreement;
, meropenem; MIN, minocycline; NT, not tested; PTZ, piperacillin/tazobactam; SUL,
etry minimal inhibitory concentration testing in extensively drug
y and Infection, https://doi.org/10.1016/j.cmi.2020.01.026
Fig. 1. Comparison of IMC and ISO-BMD methods for determining MICs. IMC, isothermal microcalorimetry. ISO-BMD, ISO-broth microdilution.
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We present here the accuracy of a multichannel IMC device,
calScreener, for determination of MIC for bacterial pathogens
against various antibiotics. A multicentre evaluation of the method
was performed by including four commonly encountered Gram-
negative bacterial species that cause clinical infections and tested
against a panel of clinically relevant antibiotics. Average essential
agreement and categorical agreement of the IMC method were
96.6% and 97.1% when tested using the clinical isolates. The method
demonstrated excellent reproducibility when performed and
interpreted independently at each of the four study sites with the
same panel of reference strains and antibiotics.
Categorical agreements of the IMC method varied between the
antibiotics tested (Table 3), bacterial species (Table 4) and most
importantly the time (Fig. 3) at which the results were determined
in the present study. In general, the performance of any new AST
method can signiﬁcantly vary or be biased based on the charac-
teristics of challenge isolates included for the evaluation [1]. One of
the major strengths of our study is that we used challenge isolates
from the frozen collections of four European referral hospitals (to
avoid the inﬂuence of clonality) that were well distributed
(Table 2), with reference to their MICs against important antibiotics
of clinical relevance. By doing so, we were able to investigate the
categorical agreement of the IMCmethod using calScreener against
a challenging strain collection, thus provoking the system maxi-
mally. IMC data from four (1.2%) of 320 isolates did not meet the
technical inclusion criteria and hence were not included in the ﬁnal
analysis. A re-run of these four samples could resolve the technical
uncertainty and allow for a MIC determination. Overall the error
rates of the IMC method by the end of 18 hours ranged between 1%Please cite this article as: Tellapragada C et al., Isothermal microcalorim
resistant Gram-negative bacilli: a multicentre study, Clinical Microbiologand 3.7% among the four bacterial species tested. The IMC method
performed well in predicting the MIC among Enterobacterales iso-
lates (n ¼ 159), sparing the three major errors when tested against
ciproﬂoxacin and two minor errors against meropenem.
EUCAST has identiﬁed some situations when reproducibility of
AST, including sometimes also BMD, is particularly challenging.
These MIC values or sometimes ranges of values are referred to as
the area of technical uncertainty for certain antibiotics that are
more prone to generate categorical errors while testing using the
BMD method. Four of the 77 P. aeruginosa isolates included in the
study had an MIC of 4 mg/L, determined using the reference
method against colistin, which is recognized as an area of technical
uncertainty for colistin among P. aeruginosa by EUCAST. The IMC
method identiﬁed two of these four isolates as susceptible (false)
and one isolate as resistant (false), leading to 33.3% VME and 1.4%
ME. The concept of the area of technical uncertainty has only been
available since January 2019, so it has not yet been fully established
whether it should be considered when calculating errors in AST.
Nevertheless, some of the observed discrepancies could clearly be
explained by the problems of reproducible AST with colistin and
P. aeruginosa, which apply to all MIC methods.
With increasing number of infections due tomultidrug-resistant
A. baumannii, minocycline and sulbactam have sometimes been
suggested as therapeutic options, mostly in combination with
another agent. MIC breakpoints for these drugs against
A. baumannii are currently not available from EUCAST [10,11]. The
IMC method generated VME more frequently while determining
MICs for sulbactam and minocycline. Establishing susceptibility for
these two antibiotics was reported to be problematic using several
available AST methods [12]. We foresee the need for further eval-
uation of the IMC method for its accuracy in predicting MICs foretry minimal inhibitory concentration testing in extensively drug
y and Infection, https://doi.org/10.1016/j.cmi.2020.01.026
Fig. 2. TTD of MICs among four bacterial species tested. (a) TTD of stable metabolic activity among each of four bacterial species tested in absence of antibiotics. (bee) Repre-
sentation of range and median time needed for determination of MICs against each antibiotic tested for (b), Escherichia coli (c), Klebsiella pneumoniae (d), Pseudomonas aeruginosa
(e), Acinetobacter baumannii. TTD, time to detection.
Fig. 3. Comparison of categorical errors by isothermal microcalorimetry (IMC) method at 8- and 18-hour time points.
C. Tellapragada et al. / Clinical Microbiology and Infection xxx (xxxx) xxx6these two antibiotics, using a large comprehensive collection of
A. baumannii isolates comprising both wild-type and resistant
phenotypes to draw any conclusions.
Essential agreement of IMC method with the reference method
for the antibiotics tested in the present study ranged between 90%
and 100%, with an average of 96.3%. It is possible that the results
derived from our study, with special reference to the essentialPlease cite this article as: Tellapragada C et al., Isothermal microcalorim
resistant Gram-negative bacilli: a multicentre study, Clinical Microbiologagreement of the IMC method, could have been slightly different if
only the exact MICs were determined instead of truncations in the
highest and lowest MIC dilutions. We recognize this as one of the
limitations of our study. Reproducibility of the IMC method was
performed using ﬁve reference strains, tested independently at
each of the four study sites using the same batch of media (MHB)
and working solutions of antibiotics prepared and distributedetry minimal inhibitory concentration testing in extensively drug
y and Infection, https://doi.org/10.1016/j.cmi.2020.01.026
C. Tellapragada et al. / Clinical Microbiology and Infection xxx (xxxx) xxx 7across all the study sites. Further, all the tests were performed by
skilled researchers with expertise in performing BMD assays.
Considering these factors, it is not surprising that both the BMD and
IMC methods demonstrated excellent reproducibility in our study.
Nevertheless, it is important to remember that the IMC method per
se is highly sensitive and, like BMD, can produce erroneous results
from minute contaminations and/or pipetting errors.
In the present study, we used 18 hours as the endpoint for MIC
determination, but attempts were made to measure MICs also after
8 hours. We did not observe a change in the percentage of ME due
to prediction ofMIC at 8 and 18 hours by the IMCmethod. However,
a considerable decline in the frequency of VME with an increase in
time for prediction from 8 to 18 hours was observed while
analyzing the results for all the ﬁve antibiotics analyzed at two
different time points (Fig. 3). From these ﬁndings, it is possible to
postulate that the time needed for determining MICs may most
likely be strain dependent within a given bacterial species. Even
though some isolates require 18 hours, many isolates could be
correctly classiﬁed in less time than the reference method. Given
this observation, we foresee the need for further evaluation of the
IMC method for its utility in predicting MICs at various time points
among Gram-negative bacilli, particularly against the last-resort
antibiotics.
In conclusion, we have shown that the determination of MICs
based on metabolic activity of bacteria could be achieved using the
new IMC device, calScreener. In some strains, the IMC method was
faster than the BMD for determining MICs. calScreener had an
additional advantage in that the bacterial growth in the presence of
antibiotics could be monitored in real time, which is not possible
with the conventional BMD testing. With further improvements in
the existing methodology used for testing and the data analysis
software, the newmethod has the potential to decrease turnaround
time for determiningMICs without compromising the quality of the
results.
Transparency declaration
The project was performed in collaboration with Symcel, which
developed the calScreener technology. CGG and RC are members ofPlease cite this article as: Tellapragada C et al., Isothermal microcalorim
resistant Gram-negative bacilli: a multicentre study, Clinical Microbiologthe Steering Committee of EUCAST. Funding was received from the
European Union’s Horizon 2020 research and innovation pro-
gramme (grant 729076). All authors report no conﬂicts of interest
relevant to this article.
References
[1] Matuschek E, Ahman J, Webster C, Kahlmeter G. Antimicrobial susceptibility
testing of colistindevaluation of seven commercial MIC products against
standard broth microdilution for Escherichia coli, Klebsiella pneumoniae,
Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect 2018;24:
865e70.
[2] Hafﬂer ZJ, Kulengowski B, Ribes JA, Burgess DS. Evaluation of the BD
Phoenix™ automated system for determining antimicrobial susceptibility
against carbapenem-resistant Enterobacteriaceae compared to broth micro-
dilution. Int J Antimicrob Agents 2019;54:249e54.
[3] Braissant O, Wirz D, G€opfert B, Daniels AU. Use of isothermal microcalorimetry
to monitor microbial activities. FEMS Microbiol Lett 2010;303:1e8.
[4] Butini ME, Abbandonato G, Di Rienzo C, Trampuz A, Di Luca M. Isothermal
microcalorimetry detects the presence of persister cells in a Staphylococcus
aureus bioﬁlm after vancomycin treatment. Front Microbiol 2019;10:332.
[5] von Ah U, Wirz D, Daniels A. Isothermal micro calorimetryda new method for
MIC determinations: results for 12 antibiotics and reference strains of E. coli
and S. aureus. BMC Microbiol 2009;9:106.
[6] Braissant O, Keiser J, Meister I, Bachmann A, Wirz D, G€opfert B, et al.
Isothermal microcalorimetry accurately detects bacteria, tumorous micro-
tissues, and parasitic worms in a label-free well-plate assay. Biotechnol J
2015;10:460e8.
[7] Wads€o I, Hallen D, Jansson M, Suurkuusk J, Wenzler T, Braissant O. A well-
plate format isothermal multi-channel microcalorimeter for monitoring the
activity of living cells and tissues. Thermochim Acta 2017;652:141e9.
[8] ISO 20776-2 Clinical laboratory testing and in vitro diagnostic test system-
sdsusceptibility testing of infectious agents and evaluation of performance of
antimicrobial susceptibility test devicesdpart 2: evaluation of performance of
antimicrobial susceptibility test devices. 2007. https://www.iso.org/standard/
41631.html.
[9] Baldoni D, Hermann H, Frei R, Trampuz A, Steinhuber A. Performance of
microcalorimetry for early detection of methicillin resistance in clinical iso-
lates of Staphylococcus aureus. J Clin Microbiol 2009;47:774e6.
[10] Tsakris A, Koumaki V, Dokoumetzidis A. Minocycline susceptibility break-
points for Acinetobacter baumannii: do we need to re-evaluate them?
J Antimicrob Chemother 2018;74:295e7.
[11] Chen H, Liu Q, Chen Z, Li C. Efﬁcacy of sulbactam for the treatment of Acine-
tobacter baumannii complex infection: a systematic review and meta-analysis.
J Infect Chemother 2017;23:278e85.
[12] Fernandez-Cuenca F, Tomas M, Caballero-Moyano FJ, Bou G, Pascual A.
Reporting antimicrobial susceptibilities and resistance phenotypes in Acine-
tobacter spp: a nationwide proﬁciency study. J Antimicrob Chemother
2017;73:692e7.etry minimal inhibitory concentration testing in extensively drug
y and Infection, https://doi.org/10.1016/j.cmi.2020.01.026
